Health secretary urged to investigate epilepsy medicine shortageHealth Secretary Matt Hancock has been urged to immediately review the epilepsy medicine supply chain, after ongoing problems Share XHealth secretary urged to investigate epilepsy medicine shortagehttps://pharmaphorum.com/news/health-secretary-urged-to-investigate-epilepsy-medicine-shortage/
Medicinal cannabis seizure prompts urgent question in ParliamentHealth secretary Matt Hancock responded to an urgent question tabled by Conservative MP Sir Mike Penning yesterday, following Share XMedicinal cannabis seizure prompts urgent question in Parliamenthttps://pharmaphorum.com/news/medicinal-cannabis-seizure-prompts-urgent-question-in-parliament/
Sanders calls on FDA to allow low-cost rivals to $375k Catalyst drugUS Senator Bernie Sanders says the FDA should allow pharmacies and generic manufacturers to make low-cost copies of Share XSanders calls on FDA to allow low-cost rivals to $375k Catalyst drughttps://pharmaphorum.com/news/sanders-calls-on-fda-to-allow-low-cost-rivals-to-375k-catalyst-drug/
Price cut unlocks NICE nod for Perjeta in post-surgery breast cancerRoche has finally won NICE backing for the use of Perjeta (pertuzumab) to prevent early-stage HER2-positive breast cancer Share XPrice cut unlocks NICE nod for Perjeta in post-surgery breast cancerhttps://pharmaphorum.com/news/price-cut-unlocks-nice-nod-for-perjeta-in-post-surgery-breast-cancer/
Doctors and patient groups struggle with CAR-T ‘hype’Managing patients’ expectations of CAR-T therapies is proving to be a huge challenge from when selection decisions are Share XDoctors and patient groups struggle with CAR-T ‘hype’https://pharmaphorum.com/news/doctors-and-patient-groups-struggle-with-car-t-hype/
Novartis makes quality of life case for Cosentyx with new dataThere is increasing recognition that skin clearance scores may not be enough to win over patients and doctors Share XNovartis makes quality of life case for Cosentyx with new datahttps://pharmaphorum.com/news/novartis-makes-quality-of-life-case-for-cosentyx-with-new-data/
Alkermes/Biogen hope for less tummy trouble with new MS pillAlkermes and Biogen have filed a new multiple sclerosis pill with the FDA, which they hope will treat Share XAlkermes/Biogen hope for less tummy trouble with new MS pillhttps://pharmaphorum.com/news/alkermes-biogen-hope-for-less-tummy-trouble-with-new-ms-pill/
Brexit affecting supplies of generic drugs, say pharmacistsBrexit is already affecting supply and prices of drugs in UK pharmacies, the BBC has reported. The BBC’s Share XBrexit affecting supplies of generic drugs, say pharmacistshttps://pharmaphorum.com/news/brexit-affecting-supplies-of-generic-drugs-say-pharmacists/
Medical devices ‘linked to deaths and injuries’ claim investigatorsMedical devices firm Medtronic has been linked to thousands of deaths and injuries, according to a report published Share XMedical devices ‘linked to deaths and injuries’ claim investigatorshttps://pharmaphorum.com/news/medical-devices-linked-to-deaths-and-injuries-claim-investigators/
